ArticleSurgery today2026
Feasibility of robotic-assisted right colectomy using the "squeezing approach".
Article in Surgery today, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeTo evaluate the initial outcomes regarding the safety and feasibility of robotic-assisted right colectomy (RRC) using the squeezing approach compared to conventional laparoscopic right colectomy (LRC).
methodsWe retrospectively compared the short-term surgical outcomes of 118 consecutive patients who underwent right colectomy using the squeezing approach for colon cancer (70 LRC and 48 RRC) at our institution between April 2022 and December 2025.
resultsThe median operative time was significantly longer in the RRC group than in the LRC group (219.0 min vs. 189.0 min, p < 0.0001). However, the median estimated blood loss was equivalent and minimal in both groups (0.0 mL vs. 0.0 mL, p = 0.9035). There was no significant difference in the median number of harvested lymph nodes (21.5 vs. 23.0, p = 0.7506). RRC demonstrated safety, with outcomes comparable to LRC in terms of the rate of conversion to open surgery (2.1% vs. 5.7%, p = 0.6194), Clavien-Dindo Grade II complications (8.3% vs. 11.4%, p = 0.741), and Grade III complications (2.1% vs. 2.9%, p = 1.000).
conclusionsThe squeezing approach enables safe and feasible RRC, thereby achieving perioperative outcomes comparable to LRC, even during the initial implementation phase.
Indexed as
Identifiers
42831930What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.